These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9711449)

  • 1. Montelukast.
    Markham A; Faulds D
    Drugs; 1998 Aug; 56(2):251-6; discussion 257. PubMed ID: 9711449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Montelukast: a review of its therapeutic potential in persistent asthma.
    Jarvis B; Markham A
    Drugs; 2000 Apr; 59(4):891-928. PubMed ID: 10804041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montelukast: data from clinical trials in the management of asthma.
    Blake KV
    Ann Pharmacother; 1999 Dec; 33(12):1299-314. PubMed ID: 10630831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
    Leff JA; Busse WW; Pearlman D; Bronsky EA; Kemp J; Hendeles L; Dockhorn R; Kundu S; Zhang J; Seidenberg BC; Reiss TF
    N Engl J Med; 1998 Jul; 339(3):147-52. PubMed ID: 9664090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Montelukast: a review of its therapeutic potential in asthma in children 2 to 14 years of age.
    Muijsers RB; Noble S
    Paediatr Drugs; 2002; 4(2):123-39. PubMed ID: 11888359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine A1 receptor antagonist versus montelukast on airway reactivity and inflammation.
    Nadeem A; Obiefuna PC; Wilson CN; Mustafa SJ
    Eur J Pharmacol; 2006 Dec; 551(1-3):116-24. PubMed ID: 17027749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spotlight on montelukast in asthma in children 2 to 14 years of age.
    Muijsers RB; Noble S
    Am J Respir Med; 2002; 1(3):225-8. PubMed ID: 14720060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of exercise training and montelukast in children with mild asthma.
    Bonsignore MR; La Grutta S; Cibella F; Scichilone N; Cuttitta G; Interrante A; Marchese M; Veca M; Virzi' M; Bonanno A; Profita M; Morici G
    Med Sci Sports Exerc; 2008 Mar; 40(3):405-12. PubMed ID: 18379200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Single dose of montelukast as an effective prevention of post exercise bronchospasm in children with bronchial asthma].
    Gaszczyk G; Latoś T; Słowikowski A; Janiak B
    Med Wieku Rozwoj; 2004; 8(3 Pt 2):847-56. PubMed ID: 15858257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evidence with montelukast in the management of chronic childhood asthma.
    Becker A
    Drugs; 2000; 59 Suppl 1():29-34; discussion 43-5. PubMed ID: 10741880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
    Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
    Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
    Wahn U; Dass SB
    Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge.
    Kelly MM; Chakir J; Vethanayagam D; Boulet LP; Laviolette M; Gauldie J; O'Byrne PM
    Chest; 2006 Sep; 130(3):741-53. PubMed ID: 16963671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Montelukast in asthmatic patients 6 years-14 years old with an FEV1 > 75%.
    Becker A; Swern A; Tozzi CA; Yu Q; Reiss T; Knorr B
    Curr Med Res Opin; 2004 Oct; 20(10):1651-9. PubMed ID: 15462699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise-induced bronchoconstriction in children: montelukast attenuates the immediate-phase and late-phase responses.
    Melo RE; Solé D; Naspitz CK
    J Allergy Clin Immunol; 2003 Feb; 111(2):301-7. PubMed ID: 12589349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Montelukast in childhood asthma: what is the evidence for its use?
    Amlani S; McIvor RA
    Expert Rev Respir Med; 2011 Feb; 5(1):17-25. PubMed ID: 21348582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma.
    De Lepeleire I; Reiss TF; Rochette F; Botto A; Zhang J; Kundu S; Decramer M
    Clin Pharmacol Ther; 1997 Jan; 61(1):83-92. PubMed ID: 9024176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of montelukast in the treatment of cat allergen-induced asthma in children.
    Phipatanakul W; Nowak-Wegrzyn A; Eggleston PA; Van Natta M; Kesavan J; Schuberth K; Wood RA
    J Allergy Clin Immunol; 2002 May; 109(5):794-9. PubMed ID: 11994702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do children with stable asthma benefit from addition of montelukast to inhaled corticosteroids: randomized, placebo controlled trial.
    Stelmach I; Ożarek-Hanc A; Zaczeniuk M; Stelmach W; Smejda K; Majak P; Jerzynska J; Anna J
    Pulm Pharmacol Ther; 2015 Apr; 31():42-8. PubMed ID: 25640020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Montelukast. No current use for asthma.
    Can Fam Physician; 2000 Jan; 46():86-99. PubMed ID: 10660791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.